Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug Response Diversity: A Hidden Bacterium?

Nadji Hannachi1,2, Laurence Camoin-Jau1,3

  • 1Aix Marseille Univ, IRD, APHM, MEPHI, IHU Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.

Journal of Personalized Medicine
|April 30, 2021
PubMed
Summary

Interindividual variability in drug response poses a public health challenge. Pharmacomicrobiomics explores gut bacteria

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Platelet activation and bacterial interactions: linking immunothrombosis to infectious pathophysiology.

Journal of thrombosis and haemostasis : JTH·2026
Same author

The Potential Role of Statins in Infective Endocarditis: A Meta-Analysis.

Current vascular pharmacology·2026
Same author

The impact of thrombocytopenia on mortality in infective endocarditis - a <i>meta</i>-analysis.

International journal of cardiology. Heart & vasculature·2025
Same author

Comparison between Duke, European Society of Cardiology 2015, International Society for Cardiovascular Infectious Diseases 2023, and European Society of Cardiology 2023 criteria for the diagnosis of transcatheter aortic valve replacement-related infective endocarditis.

European heart journal. Cardiovascular Imaging·2024
Same author

Should We Give Antithrombotic Therapy to Patients With Infective Endocarditis?: A Serious Question, But Unresolved.

JACC. Advances·2024
Same author

Molecular Mimicry of the Viral Spike in the SARS-CoV-2 Vaccine Possibly Triggers Transient Dysregulation of ACE2, Leading to Vascular and Coagulation Dysfunction Similar to SARS-CoV-2 Infection.

Viruses·2023

Area of Science:

  • Pharmacology
  • Microbiology
  • Genetics

Background:

  • Interindividual heterogeneity in drug response leads to ineffective treatments, toxicity, and increased healthcare costs.
  • Genetic factors and organ activity in drug metabolism partially explain treatment variability.
  • A novel field, pharmacomicrobiomics, investigates the role of microbial interactions in drug response.

Purpose of the Study:

  • To review the current state of pharmacomicrobiomics.
  • To highlight new information provided by this field.
  • To discuss challenges for clinical application.

Main Methods:

  • Literature review of pharmacomicrobiomics research.
  • Analysis of studies on gut microbiota and drug interactions.
Keywords:
bacteriadrug responseintestinal microbiotapharmacomicrobiomics

Related Experiment Videos

  • Discussion of current challenges and future directions.

    • Main Results:

    • Pharmacogenomics and drug metabolism alone do not fully explain drug response variability.
    • Gut bacteria significantly influence drug efficacy and toxicity.
    • Emerging data demonstrate specific microbial species affecting drug pharmacokinetics and pharmacodynamics.

    Conclusions:

    • Pharmacogenomics and drug metabolism alone do not fully explain drug response variability.
    • Gut bacteria significantly influence drug efficacy and toxicity.
    • Emerging data demonstrate specific microbial species affecting drug pharmacokinetics and pharmacodynamics.